Literature DB >> 15985485

Upstream transcription factor-1 gene polymorphism is associated with increased adipocyte lipolysis.

Johan Hoffstedt1, Mikael Rydén, Hans Wahrenberg, Vanessa van Harmelen, Peter Arner.   

Abstract

OBJECTIVE: Variations in lipid metabolism between individuals could be due to genetic factors. A transmission of a haplotype of the upstream transcription factor-1 (USF-1) gene containing the minor alleles at the usf1s1 and usfs2 loci is described. We investigated whether these polymorphisms are associated with adipocyte lipolysis. METHODS AND
RESULTS: A total of 196 healthy obese women were investigated for in vitro lipolysis regulation in sc fat cells, which was set in relation to the usf1s1 C-->T and usf1s2 G-->A polymorphisms in the usf1 gene. The two polymorphisms were in complete linkage disequilibrium. The usf1s1/2 T/A allele was associated with increases in the maximum lipolytic action of noradrenaline (P = 0.005), dobutamine (P = 0.008), terbutaline (P = 0.008), CGP12177 (P = 0.015), and forskolin (P = 0.006). In contrast, no significant genotype effect on lipolytic sensitivity (i.e. half-maximum effective concentration) for any of the drugs was demonstrated. Analysis of adipose tissue mRNA expression in 78 women from genes regulating lipolysis at the postadrenoceptor level showed an increased level of protein kinase A subunit R1alpha in the T/A genotype (P = 0.02).
CONCLUSIONS: Polymorphism in the usf1 gene is associated with increased lipolytic effect of catecholamines in fat cells, which is localized at the postadrenoceptor level, possibly, at least, involving protein kinase A.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15985485     DOI: 10.1210/jc.2005-0399

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

Review 1.  The genetics of familial combined hyperlipidaemia.

Authors:  Martijn C G J Brouwers; Marleen M J van Greevenbroek; Coen D A Stehouwer; Jacqueline de Graaf; Anton F H Stalenhoef
Journal:  Nat Rev Endocrinol       Date:  2012-02-14       Impact factor: 43.330

2.  USF-1 genetic polymorphisms confer a high risk of nonalcoholic fatty liver disease in Chinese population.

Authors:  Ying Wang; Bai-Fang Wang; Jing Tong; Bing Chang; Bing-Yuan Wang
Journal:  Int J Clin Exp Med       Date:  2015-02-15

3.  Upstream transcription factor 1 gene polymorphisms are associated with high antilipolytic insulin sensitivity and show gene-gene interactions.

Authors:  Konstantinos Kantartzis; Andreas Fritsche; Fausto Machicao; Michael Stumvoll; Jürgen Machann; Fritz Schick; Hans-Ulrich Häring; Norbert Stefan
Journal:  J Mol Med (Berl)       Date:  2006-09-26       Impact factor: 4.599

4.  Association analysis of allelic variants of USF1 in coronary atherosclerosis.

Authors:  Kati Kristiansson; Erkki Ilveskoski; Terho Lehtimäki; Leena Peltonen; Markus Perola; Pekka J Karhunen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-02-14       Impact factor: 8.311

5.  Glucose increases hepatic lipase expression in HepG2 liver cells through upregulation of upstream stimulatory factors 1 and 2.

Authors:  D van Deursen; H Jansen; A J M Verhoeven
Journal:  Diabetologia       Date:  2008-08-30       Impact factor: 10.122

6.  Risk alleles of USF1 gene predict cardiovascular disease of women in two prospective studies.

Authors:  Kati Komulainen; Mervi Alanne; Kirsi Auro; Riika Kilpikari; Päivi Pajukanta; Janna Saarela; Pekka Ellonen; Kaisa Salminen; Sangita Kulathinal; Kari Kuulasmaa; Kaisa Silander; Veikko Salomaa; Markus Perola; Leena Peltonen
Journal:  PLoS Genet       Date:  2006-05-12       Impact factor: 5.917

7.  Upstream Transcription Factor 1 (USF1) allelic variants regulate lipoprotein metabolism in women and USF1 expression in atherosclerotic plaque.

Authors:  Yue-Mei Fan; Jussi Hernesniemi; Niku Oksala; Mari Levula; Emma Raitoharju; Auni Collings; Nina Hutri-Kähönen; Markus Juonala; Jukka Marniemi; Leo-Pekka Lyytikäinen; Ilkka Seppälä; Ari Mennander; Matti Tarkka; Antti J Kangas; Pasi Soininen; Juha Pekka Salenius; Norman Klopp; Thomas Illig; Tomi Laitinen; Mika Ala-Korpela; Reijo Laaksonen; Jorma Viikari; Mika Kähönen; Olli T Raitakari; Terho Lehtimäki
Journal:  Sci Rep       Date:  2014-04-11       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.